| Literature DB >> 23723975 |
Mohammed A Yassin1, Daniel G Datiko, Olivia Tulloch, Paulos Markos, Melkamsew Aschalew, Estifanos B Shargie, Mesay H Dangisso, Ryuichi Komatsu, Suvanand Sahu, Lucie Blok, Luis E Cuevas, Sally Theobald.
Abstract
BACKGROUND: TB Control Programmes rely on passive case-finding to detect cases. TB notification remains low in Ethiopia despite major expansion of health services. Poor rural communities face many barriers to service access. METHODS ANDEntities:
Mesh:
Year: 2013 PMID: 23723975 PMCID: PMC3664633 DOI: 10.1371/journal.pone.0063174
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Map of the implementation zone (Sidama) and the 19 districts and the control zone (Hadiya).
Components of the implementation package.
|
| At zone, district and community level. Attended by political, community and religious leaders, teachers, stakeholders, partners, health workers, HEWs and ex-TB patients. |
|
| Covered TB and the new community-based approach including; identification of TB symptomatic individuals, sputum collection, quality assessment, preparing and fixing smears at community level, universal precautions for infection control and slide storage, recording and reporting, treatment support and follow-up and drug side effects. |
|
| Refresher training for staff involved in TB control activities and district supervisors. Fluorescent microscopes (light-emitting diodes – LED-FM) were distributed to laboratories (one per district and one for the Reference laboratory). Laboratory technicians received training on FM staining, smear grading and external quality assessment (EQA) procedures. |
|
| Key messages about TB and availability of services within the communities were conveyed during community meetings, campaigns and through local radio. |
|
| House-to-house visits, informing symptomatic individuals to produce and submit good quality sputum samples, preparing and fixing smears in the health posts. Two sputum specimens were collected on-the spot and the next morning. Patients’ information recorded on the slides and logbooks and HEWs used mobile phones to contact supervisors to arrange transportation of smeared slides. |
|
| Supervisors collected slides from HEWs and transported them to health centers. Laboratory technicians stained smears using Ziehl-Neelsen and/or Auramine and examined under light or Fluorescent microscopes, grade smears based international and kept slides for EQA and recorded patients’ details in the laboratory register. Laboratories performing LED-FM received training and on-site visits from senior laboratory technologists and were certified to do fluorescent microscopy. |
|
| Supervisors collected results from laboratory technicians, registered patients and initiated anti-TB treatment for PTB+ cases in their residences. Supervisors also screened household contacts of PTB+ cases (all household contacts living in the same shelter/house with the index PTB+ cases) and initiated Isoniazid preventive therapy (IPT) for asymptomatic children aged less than 5 years. Symptomatic children were referred for further examination (e.g. X-ray). |
|
| HEWs supported and monitored treatment, reported drug side-effects and treatment outcome, followed smear-negative cases, collected sputum samples again or referred patients to health centers/hospitals for further investigation. |
|
| Supervisors supported the routine recording and reporting systems, updated registers and harmonized results with TB focal persons. |
|
| Quarterly reports submitted to the NTP/MOH and TB REACH for feedback; feedback from EQA shared with laboratory technicians. |
|
| Regular review meetings were conducted with NTP staff, district supervisors and HEWs to discuss achievements, challenges and follow-up actions. Activities and performance were monitored by the field team and the NTP and an independent M&E expert contracted by TB REACH evaluated the performance and feedback used to improve quality and performance. Routine quarterly surveillance data were collected from the control zone and any change/new interventions related to TB control activities were monitored and documented. |
Figure 2Schematic representation of the intervention package and the current passive case finding approach.
Comparison of TB screening and diagnosis in implementation zone prior and during the implementation periods.
| Activity | Baseline | Project period | Additionality | Remarks |
| (June 2009–Sep 10) | (Oct 2010–Dec 2011) | |||
| TB symptomatic individuals screened at community level | 0 | 49,857 | 49,857 | 60% women |
| PTB+ cases detected at community level | 0 | 2,262 | 2,262 | 54% women |
| TB symptomatic individuals screened in the zone | 12,800 | 58,909 | 46,109 | 58% women |
| All PTB+ cases detected | 2,534 | 5,090 | 2,556 | |
| PTB+ case notification rate (per 100,000) per year (95%CI) | 64 (62·5–65·8) | 127 (123·8–131·2) | 63 | |
| All forms of TB diagnosed and initiated treatment | 3,968 | 7,071 | 3,102 | 46% women |
| Contact traced (screened) | 0 | 8,005 (1,290) | 8,005 | 2,906 index case |
| TB cases among contacts | 0 | 69 | 69 | 62 PTB+, 28 females |
| Contact children age <5 years old offered IPT | 0 | 1,080 | 1,080 | |
| IPT completion rate | 0 | 92% (643/698) | 643 | Jul-Dec 2011 cohort |
| Treatment success rate (PTB+) | 77% | 93% | 16% | |
| Defaulter rate (PTB+) | 11% | 3% | 8% |
Type of TB screening used and proportion of PTB+ cases detected and registered for treatment using different case finding approaches.
| Main outcomes | Symptomaticindividuals tested | PTB+ detected | PTB+ casesinitiated treatment |
| Case finding by HEWs (active case finding) | 49,857 | 1262 (4·5%) | 1262 (100%) |
| Case finding by health facilities (passive case finding) | 9000 | 2828 (31%) | 2828 (100%) |
| Case finding among contacts of PTB+ cases (by supervisors and HEWs) | 1290 | 62 (4·8%) | 62 (100%) |
PTB+ = Smear-positive pulmonary Tuberculosis, HEW = Health Extension Workers;
Smear-positive TB cases referred from other centres included.
Age and sex distribution of new PTB+ cases diagnosed between October 2010 and December 2011 in Sidama zone.
| Reporting period | Sex | 0–4 | 5–14 | 15–24 | 25–34 | 35–44 | 45–54 | 55–64 | ≥65 | Total |
| Quarter 1 | M | 1 | 25 | 151 | 115 | 51 | 38 | 27 | 13 | 421 |
| F | 0 | 45 | 123 | 111 | 43 | 22 | 7 | 7 | 358 | |
| Quarter 2 | M | 3 | 37 | 175 | 149 | 75 | 75 | 16 | 15 | 545 |
| F | 3 | 51 | 128 | 184 | 69 | 64 | 24 | 15 | 538 | |
| Quarter 3 | M | 0 | 43 | 149 | 127 | 64 | 57 | 32 | 14 | 486 |
| F | 2 | 51 | 138 | 169 | 75 | 44 | 17 | 8 | 504 | |
| Quarter 4 | M | 0 | 44 | 150 | 141 | 76 | 40 | 40 | 20 | 511 |
| F | 2 | 52 | 121 | 150 | 93 | 60 | 18 | 8 | 504 | |
| Quarter 5 | M | 3 | 41 | 165 | 138 | 74 | 63 | 33 | 28 | 545 |
| F | 2 | 38 | 109 | 138 | 65 | 41 | 18 | 5 | 416 | |
| All | M | 7 | 190 | 790 | 670 | 340 | 273 | 148 | 90 | 2508 |
| F | 9 | 237 | 619 | 752 | 345 | 231 | 84 | 43 | 2320 |
Figure 3Trends in number of TB cases detected before (quarter 4, 2007 to quarter 3, 2010) and during the implementation period (from quarter 4, 2010 to quarter 4, 2011) in the intervention and control zones.
Treatment outcome of cohorts registered one year prior to the project period and during the first two implementation quarters.
| Category | Cured | Completed | Treatmentsuccess | Died | Failure | Defaulter | Transferredout/not evaluated | Registered |
|
| ||||||||
| New PTB+ | 810 (42) | 666 (35) | 1476 (77) | 46 (2) | 6 (0·3) | 219 (11) | 174 (9) | 1,921 |
| PNEG | 0 (0) | 352 (75) | 352 (75) | 13 (3) | 0 (0) | 66 (14) | 40 (9) | 471 |
| EPTB | 0 (0) | 411 (76) | 411 (76) | 21 (4) | 2 (0·4) | 67 (12) | 42 (8) | 543 |
| Re-treatment | 56 (32) | 63 (36) | 119 (67) | 13 (7) | 0 (0) | 28 (16) | 17 (10) | 177 |
|
| ||||||||
| New PTB+ | 1,578 (85) | 138 (8) | 1,716 (93) | 41 (2) | 2 (0·1) | 52 (3) | 39 (2) | 1,850 |
| PNEG | 0 | 357 (91) | 357 (91) | 10 (3) | 0 | 17 (4) | 10 (3) | 394 |
| EPTB | 0 | 347 (91) | 347 (91) | 9 (2) | 0 | 13 (3) | 11 (3) | 380 |
| Re-treatment | 81 (68) | 29 (24) | 110 (92) | 1 (1) | 0 | 3 (3) | 5 (4) | 119 |
patients registered after March 2011 were still on treatment.